SpringWorks Therapeutics Inc (SWTX)
46.77
+0.08
(+0.17%)
USD |
NASDAQ |
May 01, 16:00
46.77
0.00 (0.00%)
After-Hours: 17:43
SpringWorks Therapeutics Free Cash Flow (Quarterly): -60.40M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -60.40M |
| September 30, 2023 | -54.08M |
| June 30, 2023 | -50.90M |
| March 31, 2023 | -64.80M |
| December 31, 2022 | -55.96M |
| September 30, 2022 | -23.13M |
| June 30, 2022 | -41.60M |
| March 31, 2022 | -51.08M |
| December 31, 2021 | -47.82M |
| September 30, 2021 | -27.26M |
| Date | Value |
|---|---|
| June 30, 2021 | -33.66M |
| March 31, 2021 | -21.15M |
| December 31, 2020 | 15.01M |
| September 30, 2020 | -14.87M |
| June 30, 2020 | -16.42M |
| March 31, 2020 | -16.56M |
| December 31, 2019 | -16.10M |
| September 30, 2019 | -11.20M |
| June 30, 2019 | -13.38M |
| March 31, 2019 | -7.438M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-64.80M
Minimum
Mar 2023
15.01M
Maximum
Dec 2020
-31.86M
Average
-27.26M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | -41.35M |
| Alnylam Pharmaceuticals Inc | -45.10M |
| Geron Corp | -41.00M |
| Ionis Pharmaceuticals Inc | 32.89M |
| Madrigal Pharmaceuticals Inc | -80.97M |